期刊文献+

硝苯地平联合厄贝沙坦片治疗原发性高血压临床疗效观察 被引量:6

Clinical effect of nifedipine combined with irbesartan tablets in the treatment of essential hypertension
下载PDF
导出
摘要 目的:探讨硝苯地平联合厄贝沙坦片治疗原发性高血压的临床疗效。方法:收治原发性高血压患者84例,分为对照组和试验组。对照组采用硝苯地平缓释片治疗,试验组采用硝苯地平联合厄贝沙坦片治疗,比较两组治疗效果。结果:试验组临床疗效明显高于对照组,不良反应发生率明显低于对照组(P<0.05)。结论:硝苯地平联合厄贝沙坦片治疗原发性高血压的临床疗效显著。 Objective:To explore the clinical effect of nifedipine combined with irbesartan tablets in the treatment of essentialhypertension.Methods:84patients with essential hypertension were selected.They were divided into the control group and theexperimental group.The control group was treated with extended release nifedipine tablets.The experimental group was treatedwith nifedipine combined with irbesartan tablets.We compared the therapeutic effect of two groups.Results:In the experimentalgroup,the clinical efficacy was significantly higher than that of the control group,and the adverse reaction was significantly lowerthan that of the control group(P<0.05).Conclusion:The clinical effect of nifedipine combined with irbesartan tablets in thetreatment of essential hypertension was significant.
作者 陈秋波 Chen Qiubo(Shihe Town Hospital of Fumian District,Yulin City,Guangxi 537000)
出处 《中国社区医师》 2017年第20期28-28,30,共2页 Chinese Community Doctors
关键词 硝苯地平 厄贝沙坦片 原发性高血压 Nifedipine Irbesartan tablets Essential hypertension
  • 相关文献

参考文献4

二级参考文献43

  • 1安可英,闫晓红,宓宝斌,崔建国,马慧.老年原发性高血压患者血压晨峰与年龄的相关性[J].中国老年学杂志,2015,35(1):226-227. 被引量:9
  • 2盛伟,龙黔清,杨梅,邓淑云.原发性高血压血压变异性的临床应用[J].黔南民族医专学报,2003,16(2):78-79. 被引量:7
  • 3陈捷,赵秀丽,武峰,崔艳丽,胡大一.我国14省市中老年人肥胖超重流行现状及其与高血压患病率的关系[J].中华医学杂志,2005,85(40):2830-2834. 被引量:166
  • 4陈灏珠.实用内科学.上海医科大学《实用内科学》编委会第10版,下册[M].,.1440.
  • 5叶任高.内科学.全国高等医学院校教材,第5版[M].北京:人民卫生出版社,2001.798.
  • 6Baszczuk A, Kopczyr:ski Z, Thielemann A. Endothelial dys function in patients with primary hypertension and hyperho- mocysteinemia. Postepy Hig Med Dosw (Online),2014,68: 91-100.
  • 7Cheng X. Updating the relationship between hyperhomocys- teinemia lowering therapy and cardiovascular events. Cardio- vasc Ther,2013,31: e19-e26.
  • 8Grassi G, Bombelli M, Brambilla G, et al. Total cardiovascular risk,blood pressure variability and adrenergic overdrive in hy pertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep,2012,14:333 338.
  • 9Onishi A, Morishita Y, Watanabe M, et al. Action of irbesar tan on blood pressure and glucose/lipid metabolism,in hemo dialysis patients with hypertension. Int J Gen Med, 2013,6 405-411.
  • 10丁立群,姜玲,范洁.吸烟加重高血压病患者大中动脉硬化[J].中华高血压杂志,2008,16(1):26-28. 被引量:33

同被引文献28

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部